South Korea in "no rush" to negotiate COVID-19 vaccine deals
(WSJ) The South Korean health minister announced that Korea is in no rush to make a deal. The country has been offered more than 30 milllion doses of experimental vaccines by companies such as Pfizer, Moderna, and BioNTech SE. Global optimism has soared recently after both vaccines showed effectiveness above 90%.
South Korea, whose success in combating the virus has become a global model, wants to eventually vaccinate 60% of the country's 52 million residents.
Worried that the fast-tracked vaccines might not be effective or could carry long-term side effects, South Korean health officials have stated a preference to see first how rollouts go elsewhere.